Literature DB >> 1958094

Serum soluble interleukin 2 receptor in systemic lupus erythematosus: effects of disease activity and infection.

K L Wong1, R P Wong.   

Abstract

Serum soluble interleukin 2 receptor (sIL2R) was measured in patients with active and inactive systemic lupus erythematosus (SLE). The concentration of sIL2R was higher in inactive SLE than in normal controls and was significantly increased in active compared with inactive SLE. When patients with active SLE were followed up serially it was found that the sIL2R concentration fell when the disease became inactive. There was no statistically significant association between sIL2R and the grades of disease activity, however. In patients with either active or inactive SLE and infection the sIL2R concentration was much higher than in those without infection. Chronic infection (tuberculosis or candida) was associated with a much higher concentration of sIL2R than pyogenic or herpes zoster infection. The sIL2R concentration helps to distinguish infection in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958094      PMCID: PMC1004536          DOI: 10.1136/ard.50.10.706

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  Interleukin 2 receptors are released by cells in vitro and in vivo. I. Detection of soluble IL 2 receptors in cell culture supernatants and in the serum of mice by an immunoradiometric assay.

Authors:  H Osawa; O Josimovic-Alasevic; T Diamantstein
Journal:  Eur J Immunol       Date:  1986-04       Impact factor: 5.532

2.  Immunological reactivity in patients with systemic lupus erythematosus. Humoral antibody and cellular immune responses.

Authors:  T Abe; M Homma
Journal:  Acta Rheumatol Scand       Date:  1971

Review 3.  Immunologic and genetic factors in autoimmune diseases.

Authors:  Y Shoenfeld; R S Schwartz
Journal:  N Engl J Med       Date:  1984-10-18       Impact factor: 91.245

4.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

5.  Signals required for activation and growth of autoimmune T lymphocytes.

Authors:  T J Santoro; T R Malek; Y J Rosenberg; H C Morse; A D Steinberg
Journal:  J Mol Cell Immunol       Date:  1984

6.  T and B lymphocyte function in patients with lupus nephritis: correlation with renal pathology.

Authors:  J E Balow; G C Tsokos
Journal:  Clin Nephrol       Date:  1984-02       Impact factor: 0.975

7.  Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).

Authors:  M Linker-Israeli; A C Bakke; R C Kitridou; S Gendler; S Gillis; D A Horwitz
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

8.  Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy.

Authors:  M D Lockshin; E Reinitz; M L Druzin; M Murrman; D Estes
Journal:  Am J Med       Date:  1984-11       Impact factor: 4.965

9.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

10.  C-reactive protein in the differential diagnosis between infection and disease reactivation in SLE.

Authors:  M G Bravo; D Alarcon-Segovia
Journal:  J Rheumatol       Date:  1981 Mar-Apr       Impact factor: 4.666

View more
  5 in total

Review 1.  Assessment of disease activity in systemic vasculitis.

Authors:  W Y Tse; P Cockwell; C O Savage
Journal:  Postgrad Med J       Date:  1998-01       Impact factor: 2.401

2.  Serum markers of T cell activation in relapses of Wegener's granulomatosis.

Authors:  C A Stegeman; J W Tervaert; M G Huitema; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

3.  Utility of serum ferritin and soluble interleukin-2 receptor as markers of disease activity in childhood systemic lupus erythematosus.

Authors:  Nora Almutairi; Alwaleed Aljaser; Abdulaziz Almutairi; Manal Alshaikh; Abdelmoneim Eldali; Sulaiman M Al-Mayouf
Journal:  Int J Pediatr Adolesc Med       Date:  2019-07-17

4.  Biological significance of soluble IL-2 receptor.

Authors:  C Caruso; G Candore; D Cigna; A T Colucci; M A Modica
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

5.  Urinary soluble alpha chain of the interleukin-2 receptor as a biomarker of active lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.

Authors:  Waleed Hassan; Eman Behiry; Marwa Mahgoub
Journal:  Arch Rheumatol       Date:  2020-06-26       Impact factor: 1.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.